Crossmark

A comparison of new drugs approved by the FDA, the EMA, and Swissmedic: an assessment of the international harmonization of drugs

Crossref DOI link: https://doi.org/10.1007/s00228-018-2431-7

Published Online: 2018-02-22

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zeukeng, Minette-Joëlle https://orcid.org/0000-0001-9721-7289
Seoane-Vazquez, Enrique

Bonnabry, Pascal
License Information

Text and Data Mining valid from 2018-02-22
More Information

Article History

Received: 13 October 2017

Accepted: 8 February 2018

First Online: 22 February 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

: This study uses secondary readily available data available on request. The study does not constitute human subjects research.This manuscript has not been published and is not being considered for publication elsewhere. All authors meet authorship requirements and approved the manuscript.